About me
In her role as President and Chief Operating Officer, Meg oversees operations, research and development, program management, investor relations, commercial strategy, human resources, board relations and corporate affairs.
Meg joined Ovid in 2020 and previously served as Chief Strategy Officer and Chief Corporate Affairs Officer. In her tenure at Ovid, she has supported the rebuilding of Ovid’s pipeline and directing its therapeutic areas of focus in epilepsies and rare neurological conditions.
Prior to Ovid, Alexander had two-decade long career architecting strategies to create corporate value, launch medicines and mitigate risk for biopharmaceutical and Fortune 500 companies. She has guided the launch of more than 25 medicines and shaped major initiatives for leading multinational companies, including Pfizer, Novartis, Amgen, Janssen, Boehringer Ingelheim, Alnylam, BioMarin, Nestle, Coca-Cola and many others. A proven entrepreneur, Alexander founded, and scaled, the highly successful Reputation and Risk Management business at Syneos Health, one of the world’s largest clinical and commercial resource organizations.
Meg believes in the power of people and teams to create success. She was previously named a “Disruptor” and a “Rising Star” in her industry by PM360 and the Healthcare Businesswomen’s Association, respectively. She’s the mom of a wild and intelligent four-year-old and political junky. Meg grew up on Capitol Hill and graduated from The College of William and Mary where she earned a bachelor’s degree in business administration.